ArticleProceedings of the National Academy of Sciences of the United States of America2026
Functional integrity of the SEL1L-HRD1 complex is critical for endoplasmic reticulum-associated degradation and organismal viability.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
The SEL1L-HRD1 complex is the most conserved branch of endoplasmic reticulum-associated degradation (ERAD), yet whether SEL1L is strictly required for HRD1 function in mammals has remained unclear. Here, we show, using complementary in vivo and in vitro approaches, that direct SEL1L-HRD1 binding is essential for ERAD activity and neonatal survival. Three knock-in mouse models targeting this interface reveal a clear genotype-phenotype relationship: the L709P variant, which abolishes SEL1L-HRD1 association, causes complete neonatal lethality; the partially disruptive S658P variant results in partial lethality; and the P699T mutation preserves the interaction and yields normal viability. Mechanistically, our data show that the SEL1L-HRD1 interface is essential for ERAD complex formation and activity, enabling both substrate handoff and E2 enzyme recruitment, and that the L709P mutation effectively uncouples these core steps of the mammalian ERAD pathway. These findings establish SEL1L-HRD1 coupling as a core requirement for mammalian ERAD function and early postnatal viability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.